Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer.

Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer. J Urol. 2013 Jan; 189(1 Suppl):S45-50.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.